Global Clinical Trial
- All
- News
- Videos
-
Marburg Virus Outbreak in Rwanda: Spread, Symptoms, and Global Concerns
Rwanda's first Marburg virus outbreak has resulted in 11 deaths. Health officials are responding with clinical trials to address the spread. The virus, related to Ebola, can cause severe haemorrhagic fever and is often linked to fruit bats.
-
US Eager To Involve India In Covid Clinical Trials: Dr Fauci
America's top infectious disease specialist Dr Anthony Fauci on Thursday said his country is eager to involve Indian investigators in global clinical trials to evaluate the safety and efficacy of COVID-19 therapeutics.
-
"Not Rocket Science...": AIIMS Chief On Adar Poonawalla, Vaccine Supply
Predicting the global clamour for coronavirus vaccines - even as early as six months ago, when several candidates were still in late-stage clinical trials - could not have been "rocket science", AIIMS chief Dr Randeep Guleria told NDTV Friday night
-
AstraZeneca-Oxford First To Publish Final-Stage Vaccine Trial Results
Oxford University and AstraZeneca on Tuesday became the first Covid-19 vaccine makers to publish final-stage clinical trial data in a scientific journal, clearing a key hurdle in the global race to produce safe and effective drugs for the coronavirus.
-
Dr. Reddy's Shuts Key Plans, Isolates Data Centre Services After Cyberattack
Pharmaceutical giant Dr. Reddy's Laboratories today said that it had isolated all its data centre services as a preventive measure following a cyberattack. The drug maker had shut its key plants globally due to the breach at its servers, ET Now had reported, citing sources.
-
Britain's Spies Defending COVID-19 Vaccine Work, MI5 Chief Says
British spies are trying to defend COVID-19 vaccine work against hostile powers that seek to either steal or sabotage research data in the race for the global prize of a jab that could provide immunity, the head of MI5 said on Wednesday.
-
Takeda-Led COVID-19 Plasma Treatment Enters Clinical Trial With First Patient
Japan's Takeda Pharmaceutical Co said on Friday an alliance of drugmakers it spearheads has enrolled its first patient in a global clinical trial of a blood plasma treatment for COVID-19 after months of regulatory delays.
-
50,000 People Globally Part Of Phase 3 Trial Of Chinese COVID-19 Vaccine
Around 50,000 people, across a number of countries, are participating in phase 3 clinical trials of a COVID vaccine developed by the China National Biotec Group (CNBG), the company said on Saturday in a press release.
-
China To Strengthen Global Cooperation In COVID-19 Vaccine Trials
China will strengthen international cooperation in future COVID-19 clinical vaccine trials, building on earlier collaboration in vaccine development, the science and technology minister said on Sunday.
-
Vaccine For Dengue To Be Ready By 2020
Ashwini Kumar Choubey, Minister of State for Health told Rajya Sabha that the first phase of clinical trials for one of these vaccines for dengue is scheduled for 2020. Several other global vaccines for dengue are in the making.
-
Opinion: Clinical Research Organisations Looking For Indirect Tax Exemptions
The regulatory system is continuously being refined to facilitate the entry of global clinical trials, writes Mr Parashar.
-
Ebola Vaccine Found Safe, Effective in Monkeys
A single dose of an experimental Ebola virus (EBOV) vaccine, currently undergoing testing in humans, completely protects monkeys against the current outbreak strain, when given at least seven days before exposure, scientists have found.
-
China Drafts Policy on Emergency Ebola Diagnosis, Approves Products
China has drafted a policy on the emergency use of diagnostic products for the Ebola virus disease and clinical trials, the country's drug regulator said today, as the number of people affected globally by the epidemic nears 16,000.
-
Wockhardt Surges 6% on New Drug Approval
Wockhardt' two drugs WCK 771 and WCK 2349 has received QIDP status from US FDA. These two drugs will enter global phase-3 clinical trials early next year. Wockhardt is the first Indian company to get the QIDP status.
-
Slow drug test approvals put industry at risk
Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drug firms to shift operations elsewhere, adding to their costs.
-
Marburg Virus Outbreak in Rwanda: Spread, Symptoms, and Global Concerns
Rwanda's first Marburg virus outbreak has resulted in 11 deaths. Health officials are responding with clinical trials to address the spread. The virus, related to Ebola, can cause severe haemorrhagic fever and is often linked to fruit bats.
-
US Eager To Involve India In Covid Clinical Trials: Dr Fauci
America's top infectious disease specialist Dr Anthony Fauci on Thursday said his country is eager to involve Indian investigators in global clinical trials to evaluate the safety and efficacy of COVID-19 therapeutics.
-
"Not Rocket Science...": AIIMS Chief On Adar Poonawalla, Vaccine Supply
Predicting the global clamour for coronavirus vaccines - even as early as six months ago, when several candidates were still in late-stage clinical trials - could not have been "rocket science", AIIMS chief Dr Randeep Guleria told NDTV Friday night
-
AstraZeneca-Oxford First To Publish Final-Stage Vaccine Trial Results
Oxford University and AstraZeneca on Tuesday became the first Covid-19 vaccine makers to publish final-stage clinical trial data in a scientific journal, clearing a key hurdle in the global race to produce safe and effective drugs for the coronavirus.
-
Dr. Reddy's Shuts Key Plans, Isolates Data Centre Services After Cyberattack
Pharmaceutical giant Dr. Reddy's Laboratories today said that it had isolated all its data centre services as a preventive measure following a cyberattack. The drug maker had shut its key plants globally due to the breach at its servers, ET Now had reported, citing sources.
-
Britain's Spies Defending COVID-19 Vaccine Work, MI5 Chief Says
British spies are trying to defend COVID-19 vaccine work against hostile powers that seek to either steal or sabotage research data in the race for the global prize of a jab that could provide immunity, the head of MI5 said on Wednesday.
-
Takeda-Led COVID-19 Plasma Treatment Enters Clinical Trial With First Patient
Japan's Takeda Pharmaceutical Co said on Friday an alliance of drugmakers it spearheads has enrolled its first patient in a global clinical trial of a blood plasma treatment for COVID-19 after months of regulatory delays.
-
50,000 People Globally Part Of Phase 3 Trial Of Chinese COVID-19 Vaccine
Around 50,000 people, across a number of countries, are participating in phase 3 clinical trials of a COVID vaccine developed by the China National Biotec Group (CNBG), the company said on Saturday in a press release.
-
China To Strengthen Global Cooperation In COVID-19 Vaccine Trials
China will strengthen international cooperation in future COVID-19 clinical vaccine trials, building on earlier collaboration in vaccine development, the science and technology minister said on Sunday.
-
Vaccine For Dengue To Be Ready By 2020
Ashwini Kumar Choubey, Minister of State for Health told Rajya Sabha that the first phase of clinical trials for one of these vaccines for dengue is scheduled for 2020. Several other global vaccines for dengue are in the making.
-
Opinion: Clinical Research Organisations Looking For Indirect Tax Exemptions
The regulatory system is continuously being refined to facilitate the entry of global clinical trials, writes Mr Parashar.
-
Ebola Vaccine Found Safe, Effective in Monkeys
A single dose of an experimental Ebola virus (EBOV) vaccine, currently undergoing testing in humans, completely protects monkeys against the current outbreak strain, when given at least seven days before exposure, scientists have found.
-
China Drafts Policy on Emergency Ebola Diagnosis, Approves Products
China has drafted a policy on the emergency use of diagnostic products for the Ebola virus disease and clinical trials, the country's drug regulator said today, as the number of people affected globally by the epidemic nears 16,000.
-
Wockhardt Surges 6% on New Drug Approval
Wockhardt' two drugs WCK 771 and WCK 2349 has received QIDP status from US FDA. These two drugs will enter global phase-3 clinical trials early next year. Wockhardt is the first Indian company to get the QIDP status.
-
Slow drug test approvals put industry at risk
Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drug firms to shift operations elsewhere, adding to their costs.
